Difference between revisions of "Ferric gluconate (Ferrlecit)"
Jump to navigation
Jump to search
Warner-admin (talk | contribs) m (Text replacement - "[[Category:Drugs FDA" to "[[Category:FDA") |
m |
||
| (3 intermediate revisions by 2 users not shown) | |||
| Line 1: | Line 1: | ||
==General information== | ==General information== | ||
| − | Class/mechanism: Iron, which is needed for various biologic processes, including synthesis of hemoglobin and multiple enzymatic processes.<ref name="insert">[http://products.sanofi.us/ferrlecit/ferrlecit.pdf Ferric gluconate (Ferrlecit) package insert]</ref><ref>[[ | + | Class/mechanism: Iron, which is needed for various biologic processes, including synthesis of hemoglobin and multiple enzymatic processes.<ref name="insert">[http://products.sanofi.us/ferrlecit/ferrlecit.pdf Ferric gluconate (Ferrlecit) package insert]</ref><ref>[[:File:Ferricgluconate.pdf | Ferric gluconate (Ferrlecit) package insert (locally hosted backup)]]</ref><ref>[http://www.ferrlecit.com/default.aspx Ferrlecit manufacturer's website]</ref> |
<br>Route: IV | <br>Route: IV | ||
<br>Extravasation: no information | <br>Extravasation: no information | ||
| Line 11: | Line 11: | ||
==History of changes in FDA indication== | ==History of changes in FDA indication== | ||
| − | * | + | *1999-02-18: [http://www.accessdata.fda.gov/drugsatfda_docs/appletter/1999/20955ltr.pdf Approved] for treatment of iron deficiency anemia in patients undergoing chronic hemodialysis who are receiving supplemental erythropoetin therapy. |
==Also known as== | ==Also known as== | ||
| Line 23: | Line 23: | ||
[[Category:Intravenous medications]] | [[Category:Intravenous medications]] | ||
[[Category:Hematology medications]] | [[Category:Hematology medications]] | ||
| − | [[Category:Iron]] | + | [[Category:Iron replacement]] |
[[Category:FDA approved in 1999]] | [[Category:FDA approved in 1999]] | ||
Latest revision as of 09:39, 1 July 2023
General information
Class/mechanism: Iron, which is needed for various biologic processes, including synthesis of hemoglobin and multiple enzymatic processes.[1][2][3]
Route: IV
Extravasation: no information
- 1 mL of Ferrlecit provides 12.5 mg of elemental iron
For conciseness and simplicity, HemOnc.org currently will focus on treatment regimens and not list information such as: renal/hepatic dose adjustments, metabolism (including CYP450), excretion, monitoring parameters (although this will be considered for checklists), or manufacturer. Instead, for the most current information, please refer to your preferred pharmacopeias such as Micromedex, Lexicomp, UpToDate (courtesy of Lexicomp), or the prescribing information.[1]
Patient drug information
History of changes in FDA indication
- 1999-02-18: Approved for treatment of iron deficiency anemia in patients undergoing chronic hemodialysis who are receiving supplemental erythropoetin therapy.
Also known as
- Generic name: sodium ferric gluconate complex in sucrose injection
- Brand name: Ferrlecit